Trends in Nanoparticles for Leishmania Treatment: A Bibliometric and Network Analysis
dc.contributor.author | Mazón Ortiz, Gabriel | |
dc.contributor.author | Cerda Mejía, Galo | |
dc.contributor.author | Gutiérrez Morales, Eberto | |
dc.contributor.author | Diéguez Santana, Karel | |
dc.contributor.author | Ruso, Juan M. | |
dc.contributor.author | González Díaz, Humberto | |
dc.date.accessioned | 2024-01-22T16:04:01Z | |
dc.date.available | 2024-01-22T16:04:01Z | |
dc.date.issued | 2023-10-28 | |
dc.identifier.citation | Diseases 11(4) : (2023) // Article ID 153 | es_ES |
dc.identifier.issn | 2079-9721 | |
dc.identifier.uri | http://hdl.handle.net/10810/64198 | |
dc.description.abstract | Leishmaniasis is a neglected tropical illness with a wide variety of clinical signs ranging from visceral to cutaneous symptoms, resulting in millions of new cases and thousands of fatalities reported annually. This article provides a bibliometric analysis of the main authors’ contributions, institutions, and nations in terms of productivity, citations, and bibliographic linkages to the appli- cation of nanoparticles (NPs) for the treatment of leishmania. The study is based on a sample of 524 Scopus documents from 1991 to 2022. Utilising the Bibliometrix R-Tool version 4.0 and VOSviewer software, version 1.6.17 the analysis was developed. We identified crucial subjects associated with the application of NPs in the field of antileishmanial development (NPs and drug formulation for leishmaniasis treatment, animal models, and experiments). We selected research topics that were out of date and oversaturated. Simultaneously, we proposed developing subjects based on multiple analyses of the corpus of published scientific literature (title, abstract, and keywords). Finally, the technique used contributed to the development of a broader and more specific “big picture” of nanomedicine research in antileishmanial studies for future projects. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/es/ | |
dc.subject | nanomedicine | es_ES |
dc.subject | bibliometric analysis | es_ES |
dc.subject | network analysis | es_ES |
dc.subject | parasite diseases | es_ES |
dc.subject | leishmaniasis treatment | es_ES |
dc.subject | antiprotozoal agents | es_ES |
dc.title | Trends in Nanoparticles for Leishmania Treatment: A Bibliometric and Network Analysis | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.date.updated | 2023-12-22T13:45:17Z | |
dc.rights.holder | © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/). | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/2079-9721/11/4/153 | es_ES |
dc.identifier.doi | 10.3390/diseases11040153 | |
dc.departamentoes | Química Orgánica e Inorgánica | |
dc.departamentoeu | Kimika Organikoa eta Ez-Organikoa |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).